Medicinal Product Shortages - update - 05 June 2024

Notice type: Advisory

Date: 05/06/2024

This is the HPRA’s latest weekly update on medicines shortages. We publish this information each week to keep patients and healthcare professionals informed of current and resolved shortages.

We recognise that medicine shortages can be challenging for those who rely on medicines for their health and well-being. It is the case that for many medicines supplied in Ireland, there is more than one strength, form, pack size or brand available from different suppliers.

Your doctor or pharmacist will often be able to supply an alternative strength, form or product to ensure continuity of treatment if the medicine you have been taking is unavailable.

Resolved shortages

The following shortages have been resolved and supply has resumed to the Irish market:

Product

Active Ingredient(s)

Flucloxacillin 500mg powder for solution for injection/infusion

PA2059/069/001

Fresenius Kabi Deutschland GmbH

Flucloxacillin

Hypnovel 10mg/2ml Solution for Injection

PA2239/007/001

CHEPLAPHARM Arzneimittel GmbH

Midazolam

Ipratropium Steri-Neb 250 micrograms/ml Nebuliser solution

PA1986/083/001

Teva B.V

Ipratropium

Letrozole Teva 2.5mg Film Coated Tablets

PA0749/085/001

Teva Pharma B.V

Letrozole

Palonosetron 250 micrograms Solution for Injection

PA2059/014/001-002

Fresenius Kabi Deutschland GmbH

Palonosetron

Propess 10mg vaginal delivery system

PA1009/029/001

Ferring Ireland Ltd

Dinoprostone

Ritalin LA 20mg prolonged-release capsules

PA1972/002/002

InfectoPharm Arzneimittel und Consilium GmbH

Methylphenidate

Ritalin LA 40mg prolonged-release capsules

PA1972/002/004

InfectoPharm Arzneimittel und Consilium GmbH

Methylphenidate

Sastravi 125mg/31.25mg/200mg Film-coated Tablets

PA0549/026/002

Teva B.V

Levodopa, carbidopa &

entacapone

Stemetil 12.5 mg/ml solution for injection - 1ml Ampoule 

PA0540/127/002

Sanofi-Aventis Ireland Limited T/A

SANOFI

Prochlorperazine

Newly notified shortages

The HPRA has been notified of a shortage of the following products:

Product

Active Ingredient(s)

Aripiprazole Teva 15mg tablets

PA1986/019/003

Teva B.V.

Aripiprazole

Atomoxetine Accord 10mg Hard Capsules

PA2315/019/001

Accord Healthcare Ireland Ltd

Atomoxetine

Atomoxetine Accord 18mg Hard Capsules

PA2315/019/002

Accord Healthcare Ireland Ltd

Atomoxetine

Atomoxetine Accord 25mg Hard Capsules

PA2315/019/003

Accord Healthcare Ireland Ltd

Atomoxetine

Clarithromycin Teva 500mg Film Coated Tablets

PA0749/148/002

Teva B.V.

Clarithromycin

Luveris 75IU Powder and solvent for solution for injection

EU/1/00/155/004

Merck Europe B.V.

Lutropin alfa

Neurostil 300mg Capsules

PA0749/164/002

Teva Pharma B.V.

Gabapentin

Ozempic 0.25mg solution for Injection in pre-filled pen

EU/1/17/1251/002

Novo Nordisk A/S

Semaglutide

Please see the shortages section of the HPRA website for further information

The HPRA sends weekly updates concerning medicinal product shortages. However, the above webpage will be updated as new information is provided to the HPRA.



« Back